• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eton Pharmaceutcials Inc (NQ: ETON )

    3.320 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 20
    Open 3.320
    Bid (Size) 3.050 (70)
    Ask (Size) 4.000 (20)
    Prev. Close 3.320
    Today's Range 3.320 - 3.320
    52wk Range 2.420 - 5.810
    Shares Outstanding 25,688,062
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
    ETON stock results show that Eton Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire

    Performance

    YTD
    -27.67%
    -27.67%
    1 Month
    -7.78%
    -7.78%
    3 Month
    -11.47%
    -11.47%
    6 Month
    -27.83%
    -27.83%
    1 Year
    -0.60%
    -0.60%

    More News

    Read More
    Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Recap: Eton Pharmaceuticals Q4 Earnings
    Via Benzinga
    Eton Pharmaceuticals Earnings Preview
    Via Benzinga
    Is NASDAQ:ETON suited for growth investing?
    Via Chartmill
    Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
    From Eton Pharmaceuticals
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
    From Eton Pharmaceuticals
    Via GlobeNewswire
    ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Why the growth investor may take a look at NASDAQ:ETON.
    Via Chartmill
    Evaluating NASDAQ:ETON for Growth Investment Opportunities.
    Via Chartmill
    Eton Pharmaceuticals: Q3 Earnings Insights
    Via Benzinga
    Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Earnings Scheduled For March 14, 2024
    Via Benzinga
    Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Gilead Sciences Tops Q3 Earnings And Revenue Estimates
    Via Talk Markets
    Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    From Eton Pharmaceuticals
    Via GlobeNewswire
    Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.